Another convalescent plasma trial for Covid-19 goes bust, but some experts are still holding out hope
A large, randomized, placebo-controlled trial found that the administration of Covid-19 convalescent plasma to high-risk outpatients did not prevent the progression of Covid-19, according to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
